AIM
XENE icon

Aigen Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History

Aigen Investment Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
5,218
+1,095
+27% +$60.8K 0.09% 304
2026
Q1 		$240K Buy
+4,123
New +$190K 0.06% 382
2024
Q4 		– Sell
-7,370
Closed -$290K – 1021
2024
Q3 		$290K Sell
7,370
-1,958
-21% -$78.9K 0.06% 480
2024
Q2 		$364K Buy
9,328
+4,465
+92% +$178K 0.07% 410
2024
Q1 		$209K Sell
4,863
-3,180
-40% -$146K 0.05% 533
2023
Q4 		$370K Buy
+8,043
New +$284K 0.07% 423

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aigen Investment Management's XENE Position: Q2 2026 in Review

Aigen Investment Management increased its Xenon Pharmaceuticals (XENE) stake by 27% in Q2 2026, buying an estimated $60.8K and bringing the position to 5,218 shares worth $315K. The position accounts for 0.09% of the portfolio, ranked #304.

Aigen Investment Management first reported a position in XENE in Q4 2023 and has held it in 6 quarters since. The position peaked at $370K in Q4 2023. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Aigen Investment Management held 5,218 shares of Xenon Pharmaceuticals worth $315K as of Q2 2026.
  • Aigen Investment Management bought 1,095 Xenon Pharmaceuticals shares in Q2 2026, an estimated $60.8K.
  • Xenon Pharmaceuticals made up 0.09% of Aigen Investment Management's portfolio in Q2 2026, its #304 holding.
  • Aigen Investment Management first reported a position in Xenon Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Aigen Investment Management's Xenon Pharmaceuticals position peaked at $370K in Q4 2023.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.